CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NAO.VNS is a next-generation implantable device designed to treat drug-resistant epilepsy through vagus nerve stimulation. By using optical fibers instead of metal wires, it allows for MRI compatibility and provides real-time feedback to adapt therapy for individual patients.
19.5M world population suffer from Drug-Resistant Epilepsy (DRE) with symptoms poorly controlled. 8M are not eligible for brain surgery.
Vagus nerve stimulation is nowadays the best treatment option.
But unfortunately, current solutions do not reply to the clinical need.
They cannot adapt to each patient making the patient's therapeutic journey complicated and expensive.We created NAO.VNS, the next-generation implantable vagus nerve neurostimulator.
We replaced metal wires by optical fibres to c…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
